News | Catheters

Cardiovascular Systems Inc. announced that the first patients in the United States were treated using the OrbusNeich Teleport Microcatheter (Teleport), which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance.

Home January 31, 2019
Home
News | Hypertension

Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target of widely prescribed drugs to regulate blood pressure and kidney function. The study, published online Jan. 10 in Cell, was conducted by researchers in the Blavatnik Institute at Harvard Medical School and colleagues at Duke University Medical Center.

Home January 31, 2019
Home
A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous generation systems.
Feature | Cardiovascular Ultrasound | Dave Fornell, Editor

The higher expense and lower frame rates of 3-D cardiac ultrasound systems have limited their adoption over the past ...

Home January 31, 2019
Home
News | Cardiac Diagnostics

January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type of ...

Home January 31, 2019
Home
News | Cath Lab

Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack. The study, published in Cell Metabolism, demonstrates for the first time that the metabolism of dead heart cells by macrophages reprograms the immune cells to launch an anti-inflammatory response and stimulate tissue repair.

Home January 30, 2019
Home
News | Congenital Heart

Rising temperatures stemming from global climate change may increase the number of infants born with congenital heart defects (CHD) in the U.S. over the next two decades, according to new research in the Journal of the American Heart Association.1 This may also result in as many as 7,000 additional cases over an 11 year-period in eight representative states — Arkansas, Texas, California, Iowa, North Carolina, Georgia, New York and Utah.

Home January 30, 2019
Home
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.
Feature | Atrial Fibrillation

January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...

Home January 30, 2019
Home
The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...

Home January 30, 2019
Home
Technology | Magnetic Resonance Imaging (MRI)

The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers.

Home January 30, 2019
Home
Technology | Chronic Total Occlusion (CTO)

XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the U.S. Food and Drug Administration (FDA) as peripheral crossing catheters. The catheters have been safely and successfully used to cross challenging lesions in both arterial chronic total occlusions (CTOs) and chronic obstructive venous lesions. The recent crossing FDA clearance adds to the previous clearances for endovascular support.

Home January 30, 2019
Home
News | Heart Valve Technology

Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation (TAVI) system.

Home January 29, 2019
Home
News | Heart Valve Technology

LivaNova PLC announced the publication of three separate studies highlighting the performance of its sutureless aortic valve, Perceval.

Home January 29, 2019
Home
The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.
Feature | Stents | Dave Fornell, Editor

There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...

Home January 29, 2019
Home
Videos | Artificial Intelligence

DAIC Editor Dave Fornell takes a tour of some of the most interesting new artificial intelligence (AI) imaging ...

Home January 28, 2019
Home
News | Cardio-oncology

The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology Patient course in Washington on Jan. 25-27, 2019. The event brought together top experts in both cardiology and oncology to review new and relevant science in this rapidly evolving field.

Home January 28, 2019
Home
Subscribe Now